Cite

HARVARD Citation

    Cavender, M. et al. (2015). The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial. European heart journal. 4 (5), pp. 468-474. [Online]. 
  
Back to record